Business
Author
Keith Howard
More from Keith Howard
Business
Business Abbott confirms $8.5bn Nutrition spin-off, cuts sales outlook
Abbott's Nutrition spin-off creates an $8.5bn standalone company by 2027, but the announcement landed alongside a trimmed 2026 sales forecast.
Business Musk confirms Tesla, SpaceX merger committees formed
Elon Musk says Tesla SpaceX merger committees have been formed to explore a tie-up, but no filing exists yet and he's walled off from the talks.
Business Capital One Stock Climbs on Q3 Beat – But Mind the EPS Gap
Capital One Q3 earnings beat forecasts and the stock jumped, but the headline EPS leans on an adjusted figure well above GAAP profit.
Business MSCI Q3 2026 Earnings: Revenue Up 12.4%, Buybacks Hit $627m
MSCI Q3 2026 earnings show 12.4% revenue growth, a 25% jump in asset-based fees and $627m of buybacks - but the GAAP numbers tell a sharper story.
Business Joel Kaplan leaving Meta as policy chief role is split in two
Joel Kaplan leaving Meta after 15 years as policy chief, with no single successor as duties split between two executives.
Business Hasbro Q3 2026 earnings: shares jump 7.4% as Magic hits $600m
Hasbro Q3 2026 earnings beat sent shares up 7.4%, as Magic: The Gathering topped $600m and guidance was raised. Here's what's real and what's one-off.
Business GE Aerospace Earnings Beat Meets a Share Price Slide
GE Aerospace's earnings beat delivered record orders and raised guidance, but shares fell nearly 4% as investors fixate on cash flow and costs.
Business Sunday Money: FICO Stock Price Jumps 14.21% on the Week
The FICO stock price led every US large-cap this week, up 14.21%, as credit-scoring peers rallied and tech names tumbled.
Business Strategy Stock Falls on MSCI Index Exclusion Threat
Strategy (MSTR) shares slide as MSCI's new non-operating company rules put the bitcoin treasury firm on an index exclusion list.
Business Netflix names Peter Rice chief content officer, Bajaria out
Netflix's chief content officer job changes hands: Bela Bajaria exits after a decade, replaced by ex-Disney executive Peter Rice from 26 October 2026.
Business CoreWeave Credit Default Swaps Hit Record 1,038bp
CoreWeave credit default swaps spiked to a record 1,038bp this week, pricing in distress even as revenue nearly tripled. Here's what the numbers show.
Business Rocket Lab Stock Falls ~12% as Neutron Launch Slips to 2027
Rocket Lab's Neutron launch delay to 2027 sent RKLB shares down sharply, even as the firm's core launch business keeps growing fast.
Business CoreWeave Stock Plunge: Shares Sink 15% on Gartner Warning
The CoreWeave stock plunge deepened on 14 October 2026 as a Gartner neocloud warning and hot US inflation data hit AI infrastructure shares.
Business OpenAI vs Apple lawsuit: ex-staffer accused of taking 100+ files
The OpenAI Apple lawsuit takes a new turn: OpenAI alleges a departing employee sent 100+ files on an unreleased product to Apple executives.
Business ASML’s $34.8bn Implied Move Pointed the Wrong Way
ASML's implied move ahead of Q3 earnings was priced at $34.8bn and 5.12%. The actual result beat on profit but shares fell to a 20-day low.
Business State Street Shares Fall ~7% Despite Earnings Beat
State Street shares fall despite a Q3 EPS beat, as a ~$40m revenue miss and thinning growth spook investors into a sharp single-day sell-off.
Business Medtronic’s MiniMed Exchange Offer Ends Oversubscribed
Medtronic's MiniMed exchange offer closed heavily oversubscribed, with just 18.29% of tendered shares accepted as it exits its diabetes spin-off entirely.
Business Johnson & Johnson talc charge wipes out 96% of quarterly profit
A Johnson & Johnson talc settlement charge erased 96% of Q3 profit even as the group raised 2026 guidance and shares fell sharply.
Business UnitedHealth Q3 2026 earnings beat masks a growth stall
UnitedHealth Q3 2026 earnings beat forecasts and lifted guidance, but revenue barely moved - the real story is margin repair, not growth.
Business Domino’s CFO Flags Flat International Same-Store Sales
Domino's finance chief expects international same-store sales to be about flat for 2026, but the bigger story is a US slowdown that hit the shares.
Business Meta Muse Wonder models launch to challenge OpenAI, Anthropic
Meta's new Muse Wonder models launch to rival OpenAI and Anthropic, with shares up as Zuckerberg claims frontier status on unverified benchmarks.
Business Admilparant Phase 3 trial hits goal, but one dose misses
Bristol Myers Squibb's admilparant Phase 3 trial met its main goal in IPF, but only the 60mg dose cleared statistical significance.
Business